Japan’s MHLW grants orphan drug designation to Vic...
Category : ODD/BTA/FTA Status 3 October 2025"Vicore Pharma Holding AB, unlocking the potential of a novel class of drugs, angiotensin II ty...
"Vicore Pharma Holding AB, unlocking the potential of a novel class of drugs, angiotensin II ty...
Clear Scientific Inc., a clinical-stage biopharmaceutical company, announced today that the U.S. Foo...
"Teva Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has grante...
Keros Therapeutics just earned a major regulatory win: the U.S. FDA has granted Orphan Drug designat...
Every few years, a breakthrough drug candidate emerges that makes people stop and pay attention. For...